Different TNFα expression elicited by glucose in monocytes from type 2 diabetes mellitus patients

Atherosclerosis

Volumn 194, Issue 2, 2007, Pages

  Chacon M R ^a   Vendrell, J ^a   Miranda, M ^a   Ceperuelo Mallafre V ^a   Megia A ^a   Gutierrrez C ^a   Fernandez Real J M ^a,b   Richart, C ^a   Garcia Espana A ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Glucose; Monocytes; TNF ; TNFR1; TNFR2; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; ENDOTOXIN; INTERLEUKIN 6;

ADULT; ARTICLE; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

CASE-CONTROL STUDIES; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; ENDOTOXINS; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34848815899     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.12.011     Document Type: Article

References (53)

1. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54 (2005) 1615-1625
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
3. Nishikawa T., Edelstein D., Du X.L., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
4. Porte Jr. D., and Schwartz M.W. Diabetes complications: why is glucose potentially toxic?. Science 272 (1996) 699-700
5. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;1(Suppl. 26): S5-20.
6. Hirsch I.B., and Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control?. J Diabetes Complications 19 (2005) 178-181
7. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 115 (2005) 1111-1119
8. Kolb H., and Mandrup-Poulsen T. An immune origin of type 2 diabetes?. Diabetologia 48 (2005) 1038-1050
9. Dandona P., Aljada A., and Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25 (2004) 4-7
10. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27 (2004) 813-823
11. Moller D.E. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 11 (2000) 212-217
12. Fernandez-Real J.M., Broch M., Ricart W., et al. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 47 (1998) 1757-1762
13. Linton M.F., and Fazio S. Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 27 Suppl. 3 (2003) S35-S40
14. Wellen K.E., and Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112 (2003) 1785-1788
15. Xu H., Barnes G.T., Yang Q., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112 (2003) 1821-1830
16. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
17. Arkan M.C., Hevener A.L., Greten F.R., et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11 (2005) 191-198
18. Morohoshi M., Fujisawa K., Uchimura I., and Numano F. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 45 (1996) 954-959
19. Guha M., Bai W., Nadler J.L., and Natarajan R. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and- independent pathways. J Biol Chem 275 (2000) 17728-17739
20. Shanmugam N., Reddy M.A., Guha M., and Natarajan R. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52 (2003) 1256-1264
21. MacEwan D.J. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 14 (2002) 477-492
22. Ceolotto G., Gallo A., Miola M., et al. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes 48 (1999) 1316-1322
23. Nagy K., Levy J., and Grunberger G. Impaired translocation of protein kinase C activity in human non-insulin-dependent diabetes mellitus. Metabolism 40 (1991) 807-813
24. Ohno Y., Aoki N., and Nishimura A. In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77 (1993) 1072-1077
25. Chang F.Y., and Shaio M.F. Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 28 (1995) 137-146
26. Sampson M.J., Davies I.R., Braschi S., Ivory K., and Hughes D.A. Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes. Atherosclerosis 167 (2003) 129-134
27. Avogaro A., Pagnin E., and Calo L. Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress. J Clin Endocrinol Metab 88 (2003) 1753-1759
28. Giulietti A., Stoffels K., Decallonne B., Overbergh L., and Mathieu C. Monocytic expression behavior of cytokines in diabetic patients upon inflammatory stimulation. Ann N Y Acad Sci 1037 (2004) 74-78
29. Fogeda M., Gallart L., Gutierrez C., et al. High expression of tumor necrosis factor alpha receptors in peripheral blood mononuclear cells of obese type 2 diabetic women. Eur Cytokine Netw 15 (2004) 60-66
30. Ginzinger D.G. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 30 (2002) 503-512
31. Hotamisligil G.S. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27 Suppl. 3 (2003) S53-S55
32. Ghanim H., Aljada A., Hofmeyer D., Syed T., Mohanty P., and Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 110 (2004) 1564-1571
33. + monocytes occurs in diabetes. Diabetes 54 (2005) 2779-2786
34. Hofmann M.A., Schiekofer S., Kanitz M., et al. Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care 21 (1998) 1310-1316
35. Dickensheets H.L., Freeman S.L., Smith M.F., and Donnelly R.P. Interleukin-10 upregulates tumor necrosis factor receptor type-II (p75) gene expression in endotoxin-stimulated human monocytes. Blood 90 (1997) 4162-4171
36. Ulmer A.J., Flad H., Rietschel T., and Mattern T. Induction of proliferation and cytokine production in human T lymphocytes by lipopolysaccharide (LPS). Toxicology 152 (2000) 37-45
37. Devaraj S., Venugopal S.K., Singh U., and Jialal I. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}. Diabetes 54 (2005) 85-91
38. Miao F., Gonzalo I.G., Lanting L., and Natarajan R. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 279 (2004) 18091-18097
39. Ceolotto G., Gallo A., Sartori M., et al. Hyperglycemia acutely increases monocyte extracellular signal-regulated kinase activity in vivo in humans. J Clin Endocrinol Metab 86 (2001) 1301-1305
40. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13 (2001) 85-94
41. Nau G.J., Richmond J.F., Schlesinger A., Jennings E.G., Lander E.S., and Young R.A. Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci USA 99 (2002) 1503-1508
42. Naitoh T., Kitahara M., and Tsuruzoe N. Tumor necrosis factor-alpha is induced through phorbol ester- and glycated human albumin-dependent pathway in THP-1 cells. Cell Signal 13 (2001) 331-334
43. Jiang C., Ting A.T., and Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391 (1998) 82-86
44. Tonelli J., Kishore P., Lee D.E., and Hawkins M. The regulation of glucose effectiveness: how glucose modulates its own production. Curr Opin Clin Nutr Metab Care 8 (2005) 450-456
45. Nielsen M.F., Basu R., Wise S., Caumo A., Cobelli C., and Rizza R.A. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake. Diabetes 47 (1998) 1735-1747
46. Mevorach M., Giacca A., Aharon Y., Hawkins M., Shamoon H., and Rossetti L. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest 102 (1998) 744-753
47. Ciaraldi T.P., Carter L., Mudaliar S., Kern P.A., and Henry R.R. Effects of tumor necrosis factor-alpha on glucose metabolism in cultured human muscle cells from nondiabetic and type 2 diabetic subjects. Endocrinology 139 (1998) 4793-4800
48. Ciaraldi T.P., Abrams L., Nikoulina S., Mudaliar S., and Henry R.R. Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 96 (1995) 2820-2827
49. Estrada D.E., Elliott E., Zinman B., et al. Regulation of glucose transport and expression of GLUT3 transporters in human circulating mononuclear cells: studies in cells from insulin-dependent diabetic and nondiabetic individuals. Metabolism 43 (1994) 591-598
50. Dimitriadis G., Maratou E., Boutati E., Psarra K., Papasteriades C., and Raptis S.A. Evaluation of glucose transport and its regulation by insulin in human monocytes using flow cytometry. Cytometry A 64 (2005) 27-33
51. Fu Y., Maianu L., Melbert B.R., and Garvey W.T. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis 32 (2004) 182-190
52. Korgun E.T., Demir R., Sedlmayr P., et al. Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes. Blood Cells Mol Dis 28 (2002) 152-159
53. Sampson M.J., Davies I.R., Brown J.C., Ivory K., and Hughes D.A. Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients. Arterioscler Thromb Vasc Biol 22 (2002) 1187-1193